Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5O40

SOD1 bound to Ebselen

Summary for 5O40
Entry DOI10.2210/pdb5o40/pdb
DescriptorSuperoxide dismutase [Cu-Zn], ZINC ION, N-phenyl-2-selanylbenzamide, ... (5 entities in total)
Functional Keywordsoxidoreductase, complex, inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight32661.27
Authors
Capper, M.J.,Wright, G.S.A.,Antonyuk, S.V.,Hasnain, S.S. (deposition date: 2017-05-25, release date: 2018-06-13, Last modification date: 2024-02-07)
Primary citationCapper, M.J.,Wright, G.S.A.,Barbieri, L.,Luchinat, E.,Mercatelli, E.,McAlary, L.,Yerbury, J.J.,O'Neill, P.M.,Antonyuk, S.V.,Banci, L.,Hasnain, S.S.
The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation.
Nat Commun, 9:1693-1693, 2018
Cited by
PubMed Abstract: Superoxide dismutase-1 (SOD1) mutants, including those with unaltered enzymatic activity, are known to cause amyotrophic lateral sclerosis (ALS). Several destabilizing factors contribute to pathogenicity including a reduced ability to complete the normal maturation process which comprises folding, metal cofactor acquisition, intra-subunit disulphide bond formation and dimerization. Immature SOD1 forms toxic oligomers and characteristic large insoluble aggregates within motor system cells. Here we report that the cysteine-reactive molecule ebselen efficiently confers the SOD1 intra-subunit disulphide and directs correct SOD1 folding, depopulating the globally unfolded precursor associated with aggregation and toxicity. Assisted formation of the unusual SOD1 cytosolic disulphide bond could have potential therapeutic applications. In less reducing environments, ebselen forms a selenylsulphide with Cys111 and restores the monomer-dimer equilibrium of A4V SOD1 to wild-type. Ebselen is therefore a potent bifunctional pharmacological chaperone for SOD1 that combines properties of the SOD1 chaperone hCCS and the recently licenced antioxidant drug, edaravone.
PubMed: 29703933
DOI: 10.1038/s41467-018-04114-x
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.5 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon